Alicia Cazorla

1.1k total citations
20 papers, 639 citations indexed

About

Alicia Cazorla is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Alicia Cazorla has authored 20 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Alicia Cazorla's work include BRCA gene mutations in cancer (8 papers), Gene expression and cancer classification (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Alicia Cazorla is often cited by papers focused on BRCA gene mutations in cancer (8 papers), Gene expression and cancer classification (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). Alicia Cazorla collaborates with scholars based in Spain, Italy and Netherlands. Alicia Cazorla's co-authors include Ana Osório, Carmen Rivas, Javier Benı́tez, Emiliano Honrado, Orland Dı́ez, Enrique Lerma, Juan C. Cigudosa, Carmen Alonso, Alicia Barroso and José Palacios and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Alicia Cazorla

20 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicia Cazorla Spain 11 302 277 254 206 138 20 639
John Blondal Canada 8 286 0.9× 193 0.7× 165 0.6× 232 1.1× 104 0.8× 10 594
Louise Quenneville Canada 10 199 0.7× 290 1.0× 165 0.6× 205 1.0× 129 0.9× 14 565
Ashleen Shadeo Canada 11 82 0.3× 399 1.4× 162 0.6× 158 0.8× 76 0.6× 13 584
Theresa A. Colligon United States 8 139 0.5× 278 1.0× 123 0.5× 297 1.4× 49 0.4× 11 705
Michele Gabree United States 7 244 0.8× 215 0.8× 160 0.6× 209 1.0× 103 0.7× 9 524
Suzanna L. Arcand Canada 18 184 0.6× 465 1.7× 231 0.9× 261 1.3× 84 0.6× 26 760
Sanne R. Martens‐de Kemp Netherlands 13 85 0.3× 337 1.2× 167 0.7× 227 1.1× 76 0.6× 18 578
Lisle E. Mose United States 12 133 0.4× 386 1.4× 241 0.9× 292 1.4× 79 0.6× 19 757
Lee Lichtenstein United States 5 136 0.5× 310 1.1× 336 1.3× 129 0.6× 91 0.7× 8 571
Magdalena Ratajska Poland 16 339 1.1× 379 1.4× 189 0.7× 206 1.0× 105 0.8× 34 654

Countries citing papers authored by Alicia Cazorla

Since Specialization
Citations

This map shows the geographic impact of Alicia Cazorla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Cazorla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Cazorla more than expected).

Fields of papers citing papers by Alicia Cazorla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicia Cazorla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Cazorla. The network helps show where Alicia Cazorla may publish in the future.

Co-authorship network of co-authors of Alicia Cazorla

This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Cazorla. A scholar is included among the top collaborators of Alicia Cazorla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Cazorla. Alicia Cazorla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madoz‐Gúrpide, Juan, Sandra Zazo, Alicia Cazorla, et al.. (2022). Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer. Cancers. 14(24). 6034–6034. 21 indexed citations
2.
Bernar, Juan, et al.. (2021). Squamous cell carcinoma arising from an epidermal inclusion cyst in breast: An extremely rare diagnosis. The Breast Journal. 27(2). 176–177. 1 indexed citations
3.
Cazorla, Alicia, et al.. (2019). IgG‐4 related mastitis, Is it so infrequent?. The Breast Journal. 26(5). 1052–1053. 3 indexed citations
4.
Peg, Vicente, Irene Sansano, Begoña Vieites, et al.. (2017). Role of total tumour load of sentinel lymph node on survival in early breast cancer patients. The Breast. 33. 8–13. 34 indexed citations
5.
Rico, Daniel, Ana Osório, Miguel Urioste, et al.. (2013). DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas. British Journal of Cancer. 108(8). 1732–1742. 11 indexed citations
6.
Aragón, Carmen, et al.. (2013). Rhinomucormycosis and type 1 diabetes mellitus. Endocrinología y Nutrición (English Edition). 60(3). 149–151. 1 indexed citations
7.
García, María J., Alicia Cazorla, Jesús García-Donás, et al.. (2013). Phenotypic characterization of hereditary epithelial ovarian cancer based on a tissue microarray study.. PubMed. 28(1). 133–44. 2 indexed citations
8.
9.
Fernández‐Ramires, Ricardo, Gonzalo Goméz-López, Loris De Cecco, et al.. (2010). Transcriptional characteristics of familial non‐BRCA1/BRCA2 breast tumors. International Journal of Cancer. 128(11). 2635–2644. 10 indexed citations
10.
Fernández‐Ramires, Ricardo, Xavier Solé, Loris De Cecco, et al.. (2009). Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis. British Journal of Cancer. 101(8). 1469–1480. 12 indexed citations
11.
Fernández‐Aceñero, María Jesús, Alicia Cazorla, & F. Manzarbeitia. (2009). Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features. Urologic Oncology Seminars and Original Investigations. 29(5). 545–549. 9 indexed citations
12.
Sastre, J., et al.. (2009). Irritative contact dermatitis due to gentian violet (methylrosaniline chloride) in an airplane passenger: a case report.. PubMed. 19(1). 67–8. 3 indexed citations
13.
Honrado, Emiliano, Ana Osório, Roger L. Milne, et al.. (2007). Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Modern Pathology. 20(12). 1298–1306. 41 indexed citations
14.
Cazorla, Alicia, et al.. (2006). Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): clinico-pathological study of three cases. European Journal of Pediatrics. 165(8). 536–539. 20 indexed citations
15.
Honrado, Emiliano, Ana Osório, Alicia Cazorla, et al.. (2005). Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Research and Treatment. 90(1). 5–14. 127 indexed citations
16.
Honrado, Emiliano, Ana Osório, José Palacios, et al.. (2005). Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer DifferentiateBRCA2-Associated Tumors. Journal of Clinical Oncology. 23(30). 7503–7511. 47 indexed citations
17.
Cazorla, Alicia, et al.. (2003). Inflammatory pseudotumor of the spleen in a patient with human immunodeficiency virus infection: a case report and review of the literature. Annals of Hematology. 82(8). 511–514. 9 indexed citations
18.
Palacios, José, Emiliano Honrado, Ana Osório, et al.. (2003). Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.. PubMed. 9(10 Pt 1). 3606–14. 134 indexed citations
19.
Cazorla, Alicia, et al.. (2002). Early diagnosis of recurrent breast cancer with FDG-PET in patients with progressive elevation of serum tumor markers.. PubMed. 46(2). 113–21. 66 indexed citations
20.
Osório, Ana, Miguel de la Hoya, Raquel Rodríguez‐López, et al.. (2002). Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. International Journal of Cancer. 99(2). 305–309. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Blondal Breakdown of academic impact, for papers by Louise Quenneville Breakdown of academic impact, for papers by Ashleen Shadeo Breakdown of academic impact, for papers by Theresa A. Colligon Breakdown of academic impact, for papers by Michele Gabree Breakdown of academic impact, for papers by Suzanna L. Arcand Breakdown of academic impact, for papers by Sanne R. Martens‐de Kemp Breakdown of academic impact, for papers by Lisle E. Mose Breakdown of academic impact, for papers by Lee Lichtenstein Breakdown of academic impact, for papers by Magdalena Ratajska
Rankless by CCL
2026